Search clinical trials for: IPH4102
Total 10 results
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
Innate PharmaActive, not recruitingLymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary SyndromeUnited States, Spain, France, Italy, Belgium, Austria, Germany, Poland
-
Innate PharmaCompletedCutaneous T-Cell LymphomaUnited States, France, Netherlands, United Kingdom
-
Innate PharmaCompletedAcute Myeloid LeukemiaFrance
-
Innate PharmaCompleted
-
Innate PharmaCompleted
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
Incyte CorporationTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Biphenotypic LeukemiaUnited States
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States